Sanofi India to double consumer healthcare biz to Rs 1,000 cr

Sanofi India (previously known as Aventis Pharma) Tuesday said it aims to double its consumer healthcare business in the next five years.

Aventis Pharma renamed as Sanofi India

Shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said here.

Aventis Pharma Q1 net dips 21% to Rs 40 cr

Aventis Pharma Thursday said its net profit declined by 20.75 percent to Rs 40.1 crore for the first quarter ended March 31, 2012, over the same period previous year.